The U.S. Department of Justice has filed a civil action against Vohra Wound Physicians Management, alleging various schemes to submit false claims for payment to Medicare. Learn more about the ongoing lawsuit and how Health Law Alliance supports wound care providers to avoid legal scrutiny.
On April 4, 2025, the Department of Justice initiated a civil action against Vohra Wound Physicians Management LLC (“Vohra”), one of the largest specialty wound care providers in the nation, alleging multiple violations of the False Claims Act. The lawsuit alleges that Vohra and its founder, Dr. Ameet Vohra, engaged in a complex scheme to overbill Medicare for debridement procedures, many of which were allegedly not performed or were not medically necessary.
In its complaint, the DOJ alleges wide-ranging efforts to overbill for debridement procedures across the Practice’s locations, including the use of a proprietary EMR system that automatically billed debridement procedures as the highest-reimbursing type of procedure, regardless of procedure type. The system allegedly inserted false clinical observations into patient charts, using pre-programmed text to create the false impression that surgical procedures were performed to evade audit scrutiny. The DOJ further alleged that Vohra intentionally failed to educate its physicians, who were not wound specialists by training, about the different types of debridement procedures and corresponding Medicare payment rules during training, pressuring physicians to perform as many debridements as possible through aggressive revenue goals and targets.
Enhanced Regulatory Oversight: Key Takeaways for Wound Care Providers
The lawsuit is a reminder of the increasing legal and regulatory scrutiny facing providers in 2025. Just last year, CMS initiated a “clawback” initiative aimed at recouping overpayments to providers with a particular emphasis on wound care procedures, citing high rates of incomplete or insufficient documentation and coding errors as common issues. In particular, OIG has signaled its intent to increase its oversight into wound care providers’ billing. In November 2024, OIG announced it would be dedicating significant resources to review Part B payments for skin substitute claims as part of its Work Plan.
While wound care has long been a target of federal enforcement activity, wound care practice continues to rapidly evolve, particularly as the aging population increases and new technologies arise. 2025 has already begun to see more widespread federal investigation of wound care practices, meaning wound care providers are under more pressure now than ever before—facing audits, investigations, and even civil and criminal penalties.
Your Partners in Navigating Wound Care’s Changing Landscape
Successfully navigating a complex regulatory environment requires expert legal guidance. With decades of experience helping providers navigate audits, minimize their financial exposure, and defend against overpayment allegations, our team partners with you to address the challenges facing your practice and help ensure your practice is prepared for any situation.
MORE ARTICLES BY CATEGORY
California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>OMIG Audit Defense New York: What the 2026 Work Plan Means for Providers
Every year, the New York Office of the Medicaid Inspector General (OMIG) releases its Work Plan outlining enforcement priorities. The 2026 plan sends a clear signal that Medicaid providers in New York are entering a far more aggressive enforcement environment.
Read More >>PBM Member Denial Audit Findings: A Growing Threat to Pharmacies
Pharmacies undergoing a Pharmacy Benefit Manager (PBM) audit are typically prepared to address inventory discrepancies and documentation issues. What many are not prepared for, however, is the increasing use of PBM member denial findings, allegations that a patient claims they did not receive and/or did not authorize the dispensing of a medication for which a claim was submitted.
Read More >>
